Radical prostatectomy for high-risk prostate cancer
Thursday, November 19th, 2009 Posted in prostatectomy | No Comments »The prostate-specific antigen (PSA) era has changed the pattern of prostate cancer at presentation. Patients now present with lower-stage, lower-risk disease. However, some patients continue to present with high-risk prostate cancer (high-risk PC), and the effect of PSA introduction on ...
Radical radiotherapy for prostate cancer is the ‘only way to go’
Tuesday, November 17th, 2009 Posted in radiation therapy | No Comments »Management options for localized prostate cancer include radical prostatectomy (RP), radiation therapy (external-beam radiation therapy [EBRT] or brachytherapy), with and without androgen-deprivation therapy (ADT), or active surveillance, also known as watchful waiting. Ultimately, the choice of treatment is determined by a ...
Anxiety and distress during active surveillance for early prostate cancer
Monday, November 16th, 2009 Posted in watchful waiting | No Comments »This study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and distress scores when compared to reference values and to groups of patients with PC ...
Chemo-radiation before prostate removal may prevent cancer recurrence
Sunday, November 15th, 2009 Posted in prostate chemotherapy, radiation therapy | No Comments »Experts agree that in men with aggressive prostate cancer, standard therapies such as radiation or surgery often fail to eliminate the cancer completely at the site of treatment. When these cancers recur, they are often fatal Recently, researchers in the Oregon ...
Parents would want their sons to have prostate cancer vaccine
Friday, November 13th, 2009 Posted in prostate cancer prevention | No Comments »If scientists will could develop a “prostate cancer vaccine” that could be given to boys some time in their youth, a large percentage of parents would want their sons to have this vaccine. The problem is that that type of ...
Prostate size growth isn’t a development cancer predictor
Thursday, November 12th, 2009 Posted in prostate cancer diagnosis | No Comments »New research study at Mayo Clinic targeted the association between prostate-specific antigen (PSA) levels and prostate size. Researchers found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study ...
Serial prostate biopsies increase risk of erectile dysfunction in men with prostate cancer on active surveillance
Wednesday, November 11th, 2009 Posted in prostate cancer risks | No Comments »A recent study at The Johns Hopkins University, Baltimore, Maryland, aimed to determine whether serial prostate needle biopsies predispose men to erectile dysfunction and/or lower urinary tract symptoms over time. Men with prostate cancer on an active surveillance protocol were administered ...
Incidence and prevalence of late gastrointestinal side effects after dose-escalated conformal radiotherapy for early prostate cancer
Tuesday, November 10th, 2009 Posted in radiation therapy | No Comments »A recent study at Clatterbridge Centre for Oncology, Bebington, United Kingdom, concluded that in men with localized prostate cancer, dose-escalated conformal radiotherapy (CFRT) improves efficacy outcomes at the cost of increased toxicity. Acording to study findings, there is a statistically significant ...
The role of biopsy core number in selecting prostate cancer patients for watchful waiting
Monday, November 9th, 2009 Posted in watchful waiting | No Comments »Watchful waiting (WW) entails a strategy by which selected men are managed expectantly with the intention of applying potentially curative treatment in case of signs of progression. While WW strategy has changed the treatment and management of low-risk prostate cancers, it must also ...
A new radiation guidelines for brachytherapy
Saturday, November 7th, 2009 Posted in radiation therapy | No Comments »According to a new guideline co-authored by Yan Yu, Ph.D., director of Medical Physics in the department of Radiation Oncology at Thomas Jefferson University, radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully ...